This CAST literature review and report looks at problems caused by the current system of asynchronous approvals for biotech crops. The authors focus on the economic effects in countries that are major global commodity exporters and importers, which show that asynchrony in the global approval of new biotech crops and the resultant risk of low level presence (LLP) puts large volumes of trade worth billions of dollars at risk.
Update – JR Simplot Ranger Russet variety (X17) and Atlantic variety (Y9) Potatoes, genetically engineered for late blight resistance, low acrylamide potential, lowered reducing sugars, and reduced black spot – The USDA Animal and Plant Health Inspection Service has “… extended deregulation to [these] two lines of [GE] potatoes …”[…]Read More »
Brazil has approved commercial use of a genetically modified sugarcane, setting a milestone for the country’s highly competitive sugar industry as this is the first time such permission has been granted anywhere in the world. Read moreRead More »